Geron Corp (NASDAQ: GERN) on Monday, soared 2.65% from the previous trading day, before settling in for the closing price of $1.51. Within the past 52 weeks, GERN’s price has moved between $1.17 and $5.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 178.45%. The company achieved an average annual earnings per share of 52.66%. With a float of $603.40 million, this company’s outstanding shares have now reached $636.92 million.
Considering the fact that the conglomerate employs 229 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 97.85%, operating margin of -115.49%, and the pretax margin is -119.54%.
Geron Corp (GERN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Geron Corp is 5.26%, while institutional ownership is 75.72%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 52.66% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Geron Corp (GERN) is currently performing well based on its current performance indicators. A quick ratio of 6.97 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Compared to the last year’s volume of 13.57 million, its volume of 7.9 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 44.48%. Additionally, its Average True Range was 0.10.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 19.49%, which indicates a significant decrease from 54.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.56% in the past 14 days, which was lower than the 91.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3984, while its 200-day Moving Average is $2.8958. Nevertheless, the first resistance level for the watch stands at $1.5833 in the near term. At $1.6167, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.6733. If the price goes on to break the first support level at $1.4933, it is likely to go to the next support level at $1.4367. Should the price break the second support level, the third support level stands at $1.4033.
Geron Corp (NASDAQ: GERN) Key Stats
Market capitalization of the company is 987.23 million based on 636,918K outstanding shares. Right now, sales total 76,990 K and income totals -174,570 K. The company made 39,600 K in profit during its latest quarter, and -19,840 K in sales during its previous quarter.
